Evidence map›Paper›PMID 30591037›Full record

ArticleBMC bioinformatics2018

Using natural language processing and machine learning to identify breast cancer local recurrence.

Zexian Zeng, Sasa Espino, Ankita Roy, Xiaoyu Li, Seema A Khan, Susan E Clare, Xia Jiang, Richard Neapolitan, Yuan Luo

Abstract read
In one paragraph

Article in BMC bioinformatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Evaluation of Algorithms Using Automated Health Plan Data to Identify Breast Cancer Recurrences.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zexian ZengDepartment of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Sasa EspinoDepartment of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Ankita RoyDepartment of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Xiaoyu LiDepartment of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Seema A KhanDepartment of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Susan E ClareDepartment of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Xia JiangDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.
Richard NeapolitanDepartment of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Yuan LuoDepartment of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. yuan.luo@northwestern.edu.

Funding

A New Generation Clinical Decision Support SystemR01LM011663 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JIANG, XIA, NEAPOLITAN, RICHARD E · 2014 to 2017
$2.0M
Multidimensional Computer Adaptive Testing for Patient Reported OutcomesR01LM011962 · NLM · NORTHWESTERN UNIVERSITY AT CHICAGO · PI NEAPOLITAN, RICHARD E · 2015 to 2018
$1.3M
Bayesian Generative Methods for Extracting and Modeling Relations in EHR NarrativesR21LM012618 · NLM · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LUO, YUAN · 2017 to 2018
$390k
NLM NIH HHS R01 LM011663NLM NIH HHS R01 LM011962NLM NIH HHS R21 LM012618
6 · The paper itself

Abstract

backgroundIdentifying local recurrences in breast cancer from patient data sets is important for clinical research and practice. Developing a model using natural language processing and machine learning to identify local recurrences in breast cancer patients can reduce the time-consuming work of a manual chart review.

methodsWe design a novel concept-based filter and a prediction model to detect local recurrences using EHRs. In the training dataset, we manually review a development corpus of 50 progress notes and extract partial sentences that indicate breast cancer local recurrence. We process these partial sentences to obtain a set of Unified Medical Language System (UMLS) concepts using MetaMap, and we call it positive concept set. We apply MetaMap on patients' progress notes and retain only the concepts that fall within the positive concept set. These features combined with the number of pathology reports recorded for each patient are used to train a support vector machine to identify local recurrences.

resultsWe compared our model with three baseline classifiers using either full MetaMap concepts, filtered MetaMap concepts, or bag of words. Our model achieved the best AUC (0.93 in cross-validation, 0.87 in held-out testing).

conclusionsCompared to a labor-intensive chart review, our model provides an automated way to identify breast cancer local recurrences. We expect that by minimally adapting the positive concept set, this study has the potential to be replicated at other institutions with a moderately sized training dataset.

Indexed as

Machine LearningNatural Language ProcessingBreast NeoplasmsCohort StudiesElectronic Health RecordsFemaleHumansNeoplasm Recurrence, LocalReproducibility of ResultsSupport Vector MachineUnified Medical Language SystemBreast cancer local recurrenceEHRNLPSVM

Identifiers

PMID30591037
PMCPMC6309052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.